Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial - Ferrannini, E; Ramos, S J; Salsali, A (Diabetes Care, 2010)
et al.